| Taizhou Crene Biotechnology Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (576) 8881-3233 8820-5808 +86 13396860566 | |||
![]() |
order@pharm-intermediates.com | |||
![]() |
QQ chat | |||
| Chemical manufacturer since 2011 | ||||
| chemBlink standard supplier since 2009 | ||||
| BOC Sciences | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (631) 485-4226 | |||
![]() |
info@bocsci.com | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2010 | ||||
| Classification | API >> Antineoplastic agents |
|---|---|
| Name | Nemorubicin |
| Synonyms | (1S,3S)-3-Glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 2,3,6-trideoxy-3-[(S)-2-methoxymorpholino]-alpha-L-lyxo-hexopyranoside; DMM Dox; FCE 23762; MMRDX; Methoxymorpholinyldoxorubicin |
| Molecular Structure | ![]() |
| Molecular Formula | C32H37NO13 |
| Molecular Weight | 643.64 |
| CAS Registry Number | 108852-90-0 |
| EC Number | 808-225-3 |
| Solubility | Practically insoluble (0.02 g/L) (25 ºC), Calc.* |
|---|---|
| Density | 1.55±0.1 g/cm3 (20 ºC 760 Torr), Calc.* |
| * | Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2014 ACD/Labs) |
| Hazard Classification | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||||||||
| Market Analysis Reports |
| List of Reports Available for Nemorubicin |